AAPL348.22+4.23 (+1.23%) ▲|ABBV285.19+0.39 (+0.14%) ▲|ABT102.52+2.01 (+2.00%) ▲|ACN258.74+18.48 (+7.69%) ▲|ADBE270.55+15.49 (+6.07%) ▲|AMAT375.58-33.36 (-8.16%) ▼|AMD507.93-44.79 (-8.10%) ▼|AMGN447.28+8.94 (+2.04%) ▲|AMT181.60+3.96 (+2.23%) ▲|AMZN250.38-11.99 (-4.57%) ▼|AVGO323.24-14.56 (-4.31%) ▼|AXP325.07+1.46 (+0.45%) ▲|BA187.53-4.75 (-2.47%) ▼|BAC51.10+0.32 (+0.63%) ▲|BKNG161.10+2.72 (+1.72%) ▲|BLK1,137.54-12.06 (-1.05%) ▼|BMY63.01+1.89 (+3.09%) ▲|BNY145.32-0.53 (-0.36%) ▼|BRK-B547.00+8.01 (+1.49%) ▲|C122.56-1.29 (-1.04%) ▼|CAT703.84-36.38 (-4.91%) ▼|CL97.40+4.00 (+4.28%) ▲|CMCSA22.84+0.76 (+3.44%) ▲|COF203.44-3.22 (-1.56%) ▼|COP145.64-0.03 (-0.02%) ▼|COST1,018.21+19.90 (+1.99%) ▲|CRM250.24+8.46 (+3.50%) ▲|CSCO104.89-2.37 (-2.21%) ▼|CVS94.49+1.71 (+1.84%) ▲|CVX226.65-0.13 (-0.06%) ▼|DE643.60+7.06 (+1.11%) ▲|DHR229.88-3.98 (-1.70%) ▼|DIS113.14+1.31 (+1.17%) ▲|DUK125.42+4.75 (+3.94%) ▲|EMR160.26-2.85 (-1.75%) ▼|FDX303.99+5.76 (+1.93%) ▲|GD350.76+6.05 (+1.75%) ▲|GE293.51-2.37 (-0.80%) ▼|GEV827.38-98.55 (-10.64%) ▼|GILD157.19+3.62 (+2.36%) ▲|GM77.22+1.11 (+1.46%) ▲|GOOG320.76-10.19 (-3.08%) ▼|GOOGL324.22-10.54 (-3.15%) ▼|GS891.27-13.45 (-1.49%) ▼|HD327.66+13.52 (+4.30%) ▲|HON218.31+3.58 (+1.67%) ▲|IBM252.19+0.73 (+0.29%) ▲|INTC85.49-7.47 (-8.04%) ▼|INTU354.90+19.29 (+5.75%) ▲|ISRG443.85+15.73 (+3.67%) ▲|JNJ267.68+9.90 (+3.84%) ▲|JPM336.51+1.32 (+0.39%) ▲|KO95.34+2.66 (+2.87%) ▲|LIN510.36+9.79 (+1.96%) ▲|LLY1,306.74+35.99 (+2.83%) ▲|LMT590.20+38.69 (+7.01%) ▲|LOW204.39+7.83 (+3.98%) ▲|LRCX230.15-30.66 (-11.76%) ▼|MA632.81+10.19 (+1.64%) ▲|MCD252.55+6.30 (+2.56%) ▲|MDLZ65.19+2.45 (+3.91%) ▲|MDT96.58+3.55 (+3.82%) ▲|META648.85-48.67 (-6.98%) ▼|MMM175.54+0.80 (+0.46%) ▲|MO76.07+2.24 (+3.03%) ▲|MRK147.25-2.63 (-1.75%) ▼|MS183.94-3.08 (-1.64%) ▼|MSFT521.08-11.87 (-2.23%) ▼|MU856.49-57.18 (-6.26%) ▼|NEE81.91+3.63 (+4.64%) ▲|NFLX67.05+2.01 (+3.09%) ▲|NKE38.31+0.78 (+2.08%) ▲|NOW157.00+3.88 (+2.53%) ▲|NVDA212.21-9.76 (-4.40%) ▼|ORCL125.52-3.62 (-2.80%) ▼|PEP138.83+4.13 (+3.07%) ▲|PFE30.41+0.56 (+1.88%) ▲|PG165.60+8.76 (+5.59%) ▲|PLTR196.19-5.53 (-2.74%) ▼|PM201.76+4.30 (+2.18%) ▲|QCOM172.83-5.13 (-2.88%) ▼|RTX194.71+3.11 (+1.62%) ▲|SBUX101.91+2.83 (+2.86%) ▲|SCHW91.44-0.20 (-0.22%) ▼|SO93.82+3.43 (+3.79%) ▲|SPG212.04+6.49 (+3.16%) ▲|T22.74+0.83 (+3.79%) ▲|TMO676.55-17.47 (-2.52%) ▼|TMUS158.79+5.04 (+3.28%) ▲|TSLA374.58-11.89 (-3.08%) ▼|TXN279.50-5.15 (-1.81%) ▼|UBER69.07+1.45 (+2.14%) ▲|UNH424.98+7.98 (+1.91%) ▲|UNP298.09+10.22 (+3.55%) ▲|UPS101.52+1.95 (+1.96%) ▲|USB60.02+0.97 (+1.64%) ▲|V414.34+6.49 (+1.59%) ▲|VZ45.20+1.64 (+3.76%) ▲|WFC83.01+0.59 (+0.72%) ▲|WMT121.12+3.32 (+2.82%) ▲|XOM178.23+0.14 (+0.08%) ▲|AAPL348.22+4.23 (+1.23%) ▲|ABBV285.19+0.39 (+0.14%) ▲|ABT102.52+2.01 (+2.00%) ▲|ACN258.74+18.48 (+7.69%) ▲|ADBE270.55+15.49 (+6.07%) ▲|AMAT375.58-33.36 (-8.16%) ▼|AMD507.93-44.79 (-8.10%) ▼|AMGN447.28+8.94 (+2.04%) ▲|AMT181.60+3.96 (+2.23%) ▲|AMZN250.38-11.99 (-4.57%) ▼|AVGO323.24-14.56 (-4.31%) ▼|AXP325.07+1.46 (+0.45%) ▲|BA187.53-4.75 (-2.47%) ▼|BAC51.10+0.32 (+0.63%) ▲|BKNG161.10+2.72 (+1.72%) ▲|BLK1,137.54-12.06 (-1.05%) ▼|BMY63.01+1.89 (+3.09%) ▲|BNY145.32-0.53 (-0.36%) ▼|BRK-B547.00+8.01 (+1.49%) ▲|C122.56-1.29 (-1.04%) ▼|CAT703.84-36.38 (-4.91%) ▼|CL97.40+4.00 (+4.28%) ▲|CMCSA22.84+0.76 (+3.44%) ▲|COF203.44-3.22 (-1.56%) ▼|COP145.64-0.03 (-0.02%) ▼|COST1,018.21+19.90 (+1.99%) ▲|CRM250.24+8.46 (+3.50%) ▲|CSCO104.89-2.37 (-2.21%) ▼|CVS94.49+1.71 (+1.84%) ▲|CVX226.65-0.13 (-0.06%) ▼|DE643.60+7.06 (+1.11%) ▲|DHR229.88-3.98 (-1.70%) ▼|DIS113.14+1.31 (+1.17%) ▲|DUK125.42+4.75 (+3.94%) ▲|EMR160.26-2.85 (-1.75%) ▼|FDX303.99+5.76 (+1.93%) ▲|GD350.76+6.05 (+1.75%) ▲|GE293.51-2.37 (-0.80%) ▼|GEV827.38-98.55 (-10.64%) ▼|GILD157.19+3.62 (+2.36%) ▲|GM77.22+1.11 (+1.46%) ▲|GOOG320.76-10.19 (-3.08%) ▼|GOOGL324.22-10.54 (-3.15%) ▼|GS891.27-13.45 (-1.49%) ▼|HD327.66+13.52 (+4.30%) ▲|HON218.31+3.58 (+1.67%) ▲|IBM252.19+0.73 (+0.29%) ▲|INTC85.49-7.47 (-8.04%) ▼|INTU354.90+19.29 (+5.75%) ▲|ISRG443.85+15.73 (+3.67%) ▲|JNJ267.68+9.90 (+3.84%) ▲|JPM336.51+1.32 (+0.39%) ▲|KO95.34+2.66 (+2.87%) ▲|LIN510.36+9.79 (+1.96%) ▲|LLY1,306.74+35.99 (+2.83%) ▲|LMT590.20+38.69 (+7.01%) ▲|LOW204.39+7.83 (+3.98%) ▲|LRCX230.15-30.66 (-11.76%) ▼|MA632.81+10.19 (+1.64%) ▲|MCD252.55+6.30 (+2.56%) ▲|MDLZ65.19+2.45 (+3.91%) ▲|MDT96.58+3.55 (+3.82%) ▲|META648.85-48.67 (-6.98%) ▼|MMM175.54+0.80 (+0.46%) ▲|MO76.07+2.24 (+3.03%) ▲|MRK147.25-2.63 (-1.75%) ▼|MS183.94-3.08 (-1.64%) ▼|MSFT521.08-11.87 (-2.23%) ▼|MU856.49-57.18 (-6.26%) ▼|NEE81.91+3.63 (+4.64%) ▲|NFLX67.05+2.01 (+3.09%) ▲|NKE38.31+0.78 (+2.08%) ▲|NOW157.00+3.88 (+2.53%) ▲|NVDA212.21-9.76 (-4.40%) ▼|ORCL125.52-3.62 (-2.80%) ▼|PEP138.83+4.13 (+3.07%) ▲|PFE30.41+0.56 (+1.88%) ▲|PG165.60+8.76 (+5.59%) ▲|PLTR196.19-5.53 (-2.74%) ▼|PM201.76+4.30 (+2.18%) ▲|QCOM172.83-5.13 (-2.88%) ▼|RTX194.71+3.11 (+1.62%) ▲|SBUX101.91+2.83 (+2.86%) ▲|SCHW91.44-0.20 (-0.22%) ▼|SO93.82+3.43 (+3.79%) ▲|SPG212.04+6.49 (+3.16%) ▲|T22.74+0.83 (+3.79%) ▲|TMO676.55-17.47 (-2.52%) ▼|TMUS158.79+5.04 (+3.28%) ▲|TSLA374.58-11.89 (-3.08%) ▼|TXN279.50-5.15 (-1.81%) ▼|UBER69.07+1.45 (+2.14%) ▲|UNH424.98+7.98 (+1.91%) ▲|UNP298.09+10.22 (+3.55%) ▲|UPS101.52+1.95 (+1.96%) ▲|USB60.02+0.97 (+1.64%) ▲|V414.34+6.49 (+1.59%) ▲|VZ45.20+1.64 (+3.76%) ▲|WFC83.01+0.59 (+0.72%) ▲|WMT121.12+3.32 (+2.82%) ▲|XOM178.23+0.14 (+0.08%) ▲|
19 C
New York
Thursday, October 22, 2026

Tag: focus

newsFORsourcecompanycontentinformation1releasesmarket

TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia

BANDUNG, Indonesia, June 8, 2026 /PRNewswire/ -- TotalEnergies ENEOS successfully completed Phase 2 of a rooftop solar photovoltaic (PV) project with PT. Perusahaan Industri Ceres...

Mouser Electronics Receives NXP’s Top Customer Count Asia 2025 Award For the First Time

SHANGHAI, June 2, 2026 /PRNewswire/ -- Mouser Electronics, Inc., the authorized global distributor with the newest electronic components and industrial automation products, is proud...

Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program

SAN DIEGO, June 8, 2026 /PRNewswire/ -- Sapu Bioscience LLC announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for...

BLACKYAK Hosts “Himalayan Climate Charter 2026: Namche Summit” to Advance Global Climate Action

- Highlights the climate crisis facing the Himalayas and underscores the need for international solidarity and collective action- Held in Namche Bazaar, Nepal, the...

GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company

Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas 
Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China

The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027

Zealand Pharma announces Boehringer Ingelheim’s survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while...

Company announcement No. 21 / 2026

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting...

Ingelheim, Germany - Boehringer Ingelheim today announced positive results from two global Phase III trials of its glucagon/GLP-1 dual agonist survodutide (BI 456906), SYNCHRONIZE-1 and SYNCHRONIZE-MASLD.2,4 The results demonstrate survodutide’s potential to reduce weight and therefore improve metabolic health in two distinct populations: adults living with obesity or overweight, without type 2 diabetes (SYNCHRONIZE-1),2 and adults with overweight or obesity with metabolic dysfunction-associated steatotic liver disease (MASLD) with evidence of inflammation and or fibrosis (SYNCHRONIZE-MASLD).4 Full results from SYNCHRONIZE-1 and SYNCHRONIZE-MASLD were presented today at the American Diabetes Association’s (ADA) 2026 Scientific Sessions and published simultaneously in The New England Journal of Medicine and Nature Medicine respectively.5,6

Bybit Launches IPO Express, Becoming One of First Centralized Crypto Exchanges to Offer Tokenized IPO Access, Starting With SpaceX

DUBAI, UAE, June 7, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, today announced the launch of Bybit IPO Express,...

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance 

University of Phoenix researchers publish study examining doctoral students’ attitudes toward AI chatbots and ChatGPT use in higher education

Peer-reviewed study by Center for Educational and Instructional Technology Research team highlights connections between student perceptions of AI, academic integrity concerns and reported chatbot...

ThinkCareBelieve: Week 72 of the Trump 2.0 Administration

Week 72 of the Trump Administration was filled with accomplishments. This week marked Day 500 of President Trump’s Presidency.

In HelloNation, Periodontics Expert Dr. Scott Kissel of Manhattan, NY, Details Why Microsurgical Techniques Matter in Periodontal Care

The article explains how precision-focused periodontal procedures can support tissue preservation, improve healing, and patient comfort.MANHATTAN, N.Y., June 6, 2026 /PRNewswire/ -- Why is...

All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration

NEW YORK, June 06, 2026 (GLOBE NEWSWIRE) -- All In FutureTech Alliance (Nasdaq: AIFA) (“AIFA” or the “Company”) today provided a strategic update. Following the Company’s previously announced signing of agreements to acquire a controlling interest in HyalRoute Communication Group (“HyalRoute”) and advancement of the Hainan AIFA Silicon Photonics Supercomputing Center project, the Company is further accelerating project planning, policy coordination, financing arrangements, and cross-border resource integration around its dual-engine strategy of an “AI infrastructure network powered by optical technologies” and an “AI application services matrix.”

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFocus

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers